162 related articles for article (PubMed ID: 20201889)
1. Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
Antzelevitch C; Burashnikov A
Ann N Y Acad Sci; 2010 Feb; 1188():78-86. PubMed ID: 20201889
[TBL] [Abstract][Full Text] [Related]
2. Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
Antzelevitch C; Burashnikov A
J Electrocardiol; 2009; 42(6):543-8. PubMed ID: 19698954
[TBL] [Abstract][Full Text] [Related]
3. Atrial-selective sodium channel blockers: do they exist?
Burashnikov A; Antzelevitch C
J Cardiovasc Pharmacol; 2008 Aug; 52(2):121-8. PubMed ID: 18670368
[TBL] [Abstract][Full Text] [Related]
4. Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation.
Burashnikov A; Di Diego JM; Zygmunt AC; Belardinelli L; Antzelevitch C
Ann N Y Acad Sci; 2008 Mar; 1123():105-12. PubMed ID: 18375582
[TBL] [Abstract][Full Text] [Related]
5. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
[TBL] [Abstract][Full Text] [Related]
6. The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
Aguilar M; Nattel S
J Cardiovasc Pharmacol; 2015 Nov; 66(5):432-40. PubMed ID: 25923324
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
Burashnikov A; Belardinelli L; Antzelevitch C
Heart Rhythm; 2015 Apr; 12(4):836-44. PubMed ID: 25546810
[TBL] [Abstract][Full Text] [Related]
8. Role of late sodium channel current block in the management of atrial fibrillation.
Burashnikov A; Antzelevitch C
Cardiovasc Drugs Ther; 2013 Feb; 27(1):79-89. PubMed ID: 23108433
[TBL] [Abstract][Full Text] [Related]
9. Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.
Burashnikov A; Belardinelli L; Antzelevitch C
J Pharmacol Exp Ther; 2012 Jan; 340(1):161-8. PubMed ID: 22005044
[TBL] [Abstract][Full Text] [Related]
10. Atrial-selective sodium channel block for the treatment of atrial fibrillation.
Burashnikov A; Antzelevitch C
Expert Opin Emerg Drugs; 2009 Jun; 14(2):233-49. PubMed ID: 19466903
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlates.
Comtois P; Sakabe M; Vigmond EJ; Munoz M; Texier A; Shiroshita-Takeshita A; Nattel S
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1489-504. PubMed ID: 18676686
[TBL] [Abstract][Full Text] [Related]
12. In silico optimization of atrial fibrillation-selective sodium channel blocker pharmacodynamics.
Aguilar-Shardonofsky M; Vigmond EJ; Nattel S; Comtois P
Biophys J; 2012 Mar; 102(5):951-60. PubMed ID: 22404917
[TBL] [Abstract][Full Text] [Related]
13. Ranolazine as a promising treatment option for atrial fibrillation: electrophysiologic mechanisms, experimental evidence, and clinical implications.
Fragakis N; Koskinas KC; Vassilikos V
Pacing Clin Electrophysiol; 2014 Oct; 37(10):1412-20. PubMed ID: 25138058
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model.
Kneller J; Kalifa J; Zou R; Zaitsev AV; Warren M; Berenfeld O; Vigmond EJ; Leon LJ; Nattel S; Jalife J
Circ Res; 2005 Mar; 96(5):e35-47. PubMed ID: 15731458
[TBL] [Abstract][Full Text] [Related]
15. Effect of Na+-channel blockade on the three-dimensional substrate of atrial fibrillation in a model of endo-epicardial dissociation and transmural conduction.
Gharaviri A; Verheule S; Eckstein J; Potse M; Krause R; Auricchio A; Kuijpers NHL; Schotten U
Europace; 2018 Nov; 20(suppl_3):iii69-iii76. PubMed ID: 30476060
[TBL] [Abstract][Full Text] [Related]
16. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
[TBL] [Abstract][Full Text] [Related]
17. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
Doshi D; Morrow JP
Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
[TBL] [Abstract][Full Text] [Related]
18. How Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation?
Burashnikov A; Antzelevitch C
J Atr Fibrillation; 2008; 1(2):98-107. PubMed ID: 21057583
[TBL] [Abstract][Full Text] [Related]
19. Atrial selectivity of antiarrhythmic drugs.
Ravens U; Poulet C; Wettwer E; Knaut M
J Physiol; 2013 Sep; 591(17):4087-97. PubMed ID: 23732646
[TBL] [Abstract][Full Text] [Related]
20. Novel pharmacological targets for the rhythm control management of atrial fibrillation.
Burashnikov A; Antzelevitch C
Pharmacol Ther; 2011 Dec; 132(3):300-13. PubMed ID: 21867730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
